Biomea Fusion Files 8-K on Security Holder Vote Matters

Ticker: BMEA · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1840439

Biomea Fusion, Inc. 8-K Filing Summary
FieldDetail
CompanyBiomea Fusion, Inc. (BMEA)
Form Type8-K
Filed DateJun 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, sec-filing

Related Tickers: BMEA

TL;DR

Biomea Fusion (BMEA) is calling a shareholder vote - expect news soon.

AI Summary

On June 11, 2025, Biomea Fusion, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, incorporated in Delaware with its principal executive offices in Redwood City, California, is involved in the Pharmaceutical Preparations industry.

Why It Matters

This filing signals that Biomea Fusion is engaging its shareholders on important corporate decisions, which could impact the company's future direction and shareholder value.

Risk Assessment

Risk Level: low — The filing is procedural, reporting on a vote of security holders, and does not disclose new financial or operational risks.

Key Numbers

  • 001-40335 — SEC File Number (Identifies the company's filing history with the SEC.)
  • 0001840439 — Central Index Key (Unique identifier for the filer in the SEC EDGAR system.)

Key Players & Entities

  • Biomea Fusion, Inc. (company) — Registrant
  • June 11, 2025 (date) — Earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • Redwood City, California (location) — Principal executive offices
  • 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations

FAQ

What specific matters will be submitted to a vote of Biomea Fusion's security holders?

The filing states that matters are being submitted to a vote of security holders, but the specific details of these matters are not disclosed in this particular 8-K filing.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on June 11, 2025.

Where are Biomea Fusion's principal executive offices located?

Biomea Fusion's principal executive offices are located at 900 Middlefield Road, 4th Floor, Redwood City, California 94063.

What is Biomea Fusion's Standard Industrial Classification (SIC) code?

Biomea Fusion's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

What is the company's SEC file number?

The company's SEC file number is 001-40335.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Biomea Fusion, Inc. (BMEA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.